
Evan S. Dellon
Gastroenterology · University of North Carolina at Chapel Hill
Credentials: · · ·
History
Research
Eosinophilic esophagitis: updated consensus recommendations for children and adults
Systematic review or meta-analysis · Journal of Allergy and Clinical Immunology · 2011 · 1,679 citations
Burden of gastrointestinal disease in the United States: 2012 update
Gastroenterology · 2012 · 1,502 citations
Review · Gastroenterology · 2019 · 1,164 citations

106 papers
- IH
94 papers

80 papers

77 papers

75 papers

68 papers

65 papers

63 papers
Grants
- 1980–2031
National Institute of Diabetes and Digestive and Kidney Diseases · T35
Contact PI · $562K · Univ of North Carolina Chapel Hill
- 2026–2031
A Trial of Upadacitinib for Non-Responsive Eosinophilic Esophagitis (ATUNE)
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $781.4K · Univ of North Carolina Chapel Hill
- 1996–2030
Center for Gastrointestinal Biology and Disease
National Institute of Diabetes and Digestive and Kidney Diseases · P30
Project lead · $1.3M · Univ of North Carolina Chapel Hill
- 2025–2030
Porcine Related apprOach to Multidisciplinary cOllaborative Translational ModEl Research (PROMOTER)
National Center for Advancing Translational Sciences · RC2
Contact PI · $1.5M · Univ of North Carolina Chapel Hill
Clinical trials
- 2026–2030
A Trial of Upadacitinib for Non-responsive Eosinophilic Esophagitis
Principal investigator · Not yet recruiting · Phase 2
University of North Carolina, Chapel Hill
- 2024–2026
Dupilumab for Eosinophilic Esophagitis With Severe Strictures
Principal investigator · Active not recruiting · Phase 4
University of North Carolina, Chapel Hill
- 2022–2024
24-Week Induction Study of APT-1011 in Adult Subjects With Eosinophilic Esophagitis (EoE) (FLUTE 3)
Principal investigator · Completed · Phase 3
Ellodi Pharmaceuticals, LP
- 2022–2025
The Immune Directed Individualized Elimination Therapy (iDIET) Study
Principal investigator · Completed
University of North Carolina, Chapel Hill




